อ้างอิง ของ โรคระบบหัวใจหลอดเลือด

  1. ↑ "cardiovascular", ศัพท์บัญญัติอังกฤษ-ไทย, ไทย-อังกฤษ ฉบับราชบัณฑิตยสถาน (คอมพิวเตอร์) รุ่น ๑.๑ ฉบับ ๒๕๔๕, (แพทยศาสตร์) -หัวใจร่วมหลอดเลือด
  2. ↑ "cardiovascular disease". คลังศัพท์ไทย, ฝ่ายบริการความรู้ทางวิทยาศาสตร์และเทคโนโลยี, สำนักงานพัฒนาวิทยาศาสตร์และเทคโนโลยีแห่งชาติ (สวทช). สืบค้นเมื่อ 2018-12-03.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Shanthi Mendis; Pekka Puska; Bo Norrving; World Health Organization (2011). Global Atlas on Cardiovascular Disease Prevention and Control (PDF). World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. pp. 3–18. ISBN 978-92-4-156437-3.
  4. 1 2 3 Fuster, Board on Global Health ; Valentin; Academies, Bridget B. Kelly, editors ; Institute of Medicine of the National (2010). Promoting cardiovascular health in the developing world : a critical challenge to achieve global health. Washington, D.C.: National Academies Press. pp. Chapter 2. ISBN 978-0-309-14774-3.CS1 maint: Multiple names: authors list (link)
  5. 1 2 GBD 2013 Mortality and Causes of Death, Collaborators (2014-12-17). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.
  6. ↑ McGill, HC; McMahan, CA; Gidding, SS (March 2008). "Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study". Circulation. 117 (9): 1216–27. doi:10.1161/CIRCULATIONAHA.107.717033. PMID 18316498.CS1 maint: Multiple names: authors list (link)
  7. ↑ Spinks, A; Glasziou, PP; Del Mar, CB (2013-11-05). "Antibiotics for sore throat". The Cochrane database of systematic reviews. 11: CD000023. doi:10.1002/14651858.CD000023.pub4. PMID 24190439.
  8. ↑ Sutcliffe, P; Connock, M; Gurung, T; Freeman, K; Johnson, S; Ngianga-Bakwin, K; Grove, A; Gurung, B; Morrow, S; Stranges, S; Clarke, A (2013). "Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials". PLOS ONE. 8 (12): e81970. doi:10.1371/journal.pone.0081970. PMID 24339983.
  9. ↑ Sutcliffe, P; Connock, M; Gurung, T; Freeman, K; Johnson, S; Kandala, NB; Grove, A; Gurung, B; Morrow, S; Clarke, A (September 2013). "Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews". Health technology assessment (Winchester, England). 17 (43): 1–253. doi:10.3310/hta17430. PMID 24074752.
  10. ↑ US Preventive Services Task, Force (2009-03-17). "Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 150 (6): 396–404. doi:10.7326/0003-4819-150-6-200903170-00008. PMID 19293072.
  11. ↑ Moran, AE; Forouzanfar, MH; Roth, GA; Mensah, GA; Ezzati, M; Murray, CJ; Naghavi, M (2014-04-08). "Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study". Circulation. 129 (14): 1483–92. doi:10.1161/circulationaha.113.004042. PMID 24573352.
  12. ↑ Go, AS; Mozaffarian, D; Roger, VL; Benjamin, EJ; Berry, JD; Borden, WB; Bravata, DM; Dai, S; Ford, ES; Fox, CS; Franco, S; Fullerton, HJ; Gillespie, C; Hailpern, SM; Heit, JA; Howard, VJ; Huffman, MD; Kissela, BM; Kittner, SJ; Lackland, DT; Lichtman, JH; Lisabeth, LD; Magid, D; Marcus, GM; Marelli, A; Matchar, DB; McGuire, DK; Mohler, ER; Moy, CS; Mussolino, ME; Nichol, G; Paynter, NP; Schreiner, PJ; Sorlie, PD; Stein, J; Turan, TN; Virani, SS; Wong, ND; Woo, D; Turner, MB; American Heart Association Statistics Committee and Stroke Statistics, Subcommittee (2013-01-01). "Heart disease and stroke statistics--2013 update: a report from the American Heart Association". Circulation. 127 (1): e6–e245. doi:10.1161/cir.0b013e31828124ad. PMID 23239837.
  13. ↑ Mendis, Shanthi; Puska,, Pekka; Norrving, Bo (2011). Global atlas on cardiovascular disease prevention and control (1st ed.). Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. p. 48. ISBN 9789241564373.
  14. ↑ Bridget, Kelly B; Institute of Medicine; Fuster, Valentin (2010). Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington, D.C: National Academies Press. ISBN 0-309-14774-3.CS1 maint: Multiple names: authors list (link)
  15. 1 2 Howard, BV; Wylie-Rosett, J (2002-07-23). "Sugar and cardiovascular disease: A statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association". Circulation. 106 (4): 523–7. doi:10.1161/01.cir.0000019552.77778.04. PMID 12135957.
  16. ↑ Finks, SW; Airee, A; Chow, SL; Macaulay, TE; Moranville, MP; Rogers, KC; Trujillo, TC (April 2012). "Key articles of dietary interventions that influence cardiovascular mortality". Pharmacotherapy. 32 (4): e54–87. doi:10.1002/j.1875-9114.2011.01087.x. PMID 22392596.
  17. ↑ Micha, R; Michas, G; Mozaffarian, D (December 2012). "Unprocessed red and processed meats and risk of coronary artery disease and type 2 diabetes—an updated review of the evidence". Current atherosclerosis reports. 14 (6): 515–24. doi:10.1007/s11883-012-0282-8. PMC 3483430. PMID 23001745.
  18. ↑ Mendis, Shanthi; Puska, Pekka; Norrving, Bo (2011). Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. ISBN 978-92-4-156437-3.CS1 maint: Uses authors parameter (link)
  19. ↑ Yusuf, S; Hawken, S; Ounpuu, S; และคณะ (2004). "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) : case-control study". Lancet. 364 (9438): 937–52. doi:10.1016/S0140-6736(04)17018-9. PMID 15364185.CS1 maint: Multiple names: authors list (link)
  20. 1 2 3 Finegold, JA; Asaria, P; Francis, DP (2012-12-04). "Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations". International journal of cardiology. 168 (2): 934–945. doi:10.1016/j.ijcard.2012.10.046. PMID 23218570.
  21. ↑ D'Adamo, E; Guardamagna, O; Chiarelli, F; Bartuli, A; Liccardo, D; Ferrari, F; Nobili, V (2015). "Atherogenic dyslipidemia and cardiovascular risk factors in obese children". International journal of endocrinology. 2015: 912047. doi:10.1155/2015/912047. PMC 4309297. PMID 25663838.
  22. ↑ "Understand Your Risk of Heart Attack". American Heart Association. Archived from the original on 2018-09-26.
  23. ↑ Mackay, Mensah, Mendis, et al. The Atlas of Heart Disease and Stroke. World Health Organization. January 2004.
  24. 1 2 3 4 5 6 7 Vartiainen, Jousilahti; Puska, Tuomilehto (1999). "Sex, Age, Cardiovascular Risk Factors, and coronary heart disease". Circulation. 99 (9): 1165–1172. doi:10.1161/01.cir.99.9.1165.CS1 maint: Multiple names: authors list (link)
  25. 1 2 3 4 Jani, B; Rajkumar, C (2006). "Ageing and vascular ageing". Postgrad Med J. 82 (968): 357–362. doi:10.1136/pgmj.2005.036053.CS1 maint: Multiple names: authors list (link)
  26. 1 2 3 World Heart Federation (2011-10-05). "World Heart Federation: Cardiovascular disease risk factors". Archived from the original on 2018-08-12. สืบค้นเมื่อ 2011-10-05.
  27. ↑ "Diabetes raises women's risk of heart disease more than for men". NPR.org. 2014-05-22. สืบค้นเมื่อ 2014-05-23.
  28. ↑ Jackson, R; Chambles, L; Higgins, M; Kuulasmaa, K; Wijnberg, L; Williams, D; WHO MONICA Project, ARIC Study (1999). "Sex difference in ischaemic heart disease mortality and risk factors in 46 communities: an ecologic analysis". Cardiovasc Risk Factors. 7: 43–54.CS1 maint: Uses authors parameter (link)
  29. ↑ Doll, Richard; Peto, Richard; Boreham, Jillian; Sutherland, Isabelle (June 2004). "Mortality in relation to smoking: 50 years' observations on male British doctors". BMJ (Clinical research ed.). 328 (7455): 1519. doi:10.1136/bmj.38142.554479.AE. PMC 437139. PMID 15213107.CS1 maint: Multiple names: authors list (link)
  30. ↑ World Health Organization; UNAIDS (2007-01-01). Prevention of Cardiovascular Disease. World Health Organization. pp. 3-. ISBN 978-92-4-154726-0.
  31. ↑ Booker, C.S.; Mann, J.I. (2008). "Trans fatty acids and cardiovascular health: Translation of the evidence base". Nutrition, Metabolism and Cardiovascular Diseases. 18 (6): 448–456. doi:10.1016/j.numecd.2008.02.005. ISSN 0939-4753.
  32. ↑ Remig, Valentina; Franklin, Barry; Margolis, Simeon; Kostas, Georgia; Nece, Theresa; Street, James C. (2010). "Trans Fats in America: A Review of Their Use, Consumption, Health Implications, and Regulation". Journal of the American Dietetic Association. 110 (4): 585–592. doi:10.1016/j.jada.2009.12.024. ISSN 0002-8223.
  33. ↑ Te Morenga, L. A.; Howatson, A. J.; Jones, R. M.; Mann, J. (2014). "Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids". American Journal of Clinical Nutrition. 100 (1): 65–79. doi:10.3945/ajcn.113.081521. ISSN 0002-9165.
  34. ↑ Micha, Renata; Michas, Georgios; Mozaffarian, Dariush (2012). "Unprocessed Red and Processed Meats and Risk of Coronary Artery Disease and Type 2 Diabetes - An Updated Review of the Evidence". Current Atherosclerosis Reports. 14 (6): 515–524. doi:10.1007/s11883-012-0282-8. ISSN 1523-3804. PMC 3483430. PMID 23001745.
  35. ↑ Mukamal, Kenneth J.; Chen, Chiung M.; Rao, Sowmya R.; Breslow, Rosalind A. (2010). "Alcohol Consumption and Cardiovascular Mortality Among U.S. Adults, 1987 to 2002". Journal of the American College of Cardiology. 55 (13): 1328–1335. doi:10.1016/j.jacc.2009.10.056. ISSN 0735-1097.
  36. ↑ World Health Organization (2011). Global Status Report on Alcohol and Health. World Health Organization. ISBN 978-92-4-156415-1.
  37. 1 2 3 Di Cesare, Mariachiara; Khang, Young-Ho; Asaria, Perviz; Blakely, Tony; Cowan, Melanie J; Farzadfar, Farshad; Guerrero, Ramiro; Ikeda, Nayu; Kyobutungi, Catherine; Msyamboza, Kelias P; Oum, Sophal; Lynch, John W; Marmot, Michael G; Ezzati, Majid (February 2013). "Inequalities in non-communicable diseases and effective responses". Lancet. 381 (9866): 585–597. doi:10.1016/S0140-6736(12)61851-0. PMID 23410608.CS1 maint: Multiple names: authors list (link)
  38. ↑ Mackenbach, JP; Cavelaars, AE; Kunst, AE; Groenhof, F (July 2000). "Socioeconomic inequalities in cardiovascular disease mortality; an international study". European Heart Journal. 21 (14): 1141–1151. doi:10.1053/euhj.1999.1990. PMID 10924297.CS1 maint: Multiple names: authors list (link)
  39. ↑ Clark, Alexander M; DesMeules, Marie; Luo, Wei; Amanda S, Duncan; Wielgosz, Andy (November 2009). "Socioeconomic status and cardiovascular disease: risks and implications for care". Nature reviews. Cardiology. 6 (11): 712–722. doi:10.1038/nrcardio.2009.163. PMID 19770848.CS1 maint: Multiple names: authors list (link)
  40. ↑ World Health Organization (2008). Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health : Commission on Social Determinants of Health Final Report. World Health Organization. pp. 26-. ISBN 978-92-4-156370-3.
  41. 1 2 Khallaf, Mohamed (2011). The Impact of Air Pollution on Health, Economy, Environment and Agricultural Sources. InTech. pp. 69–92. ISBN 978-953-307-528-0.
  42. 1 2 3 4 Franchini, M; Mannucci, PM (2012). "Air pollution and cardiovascular disease". Thrombosis Research. 129 (3): 230–4. doi:10.1016/j.thromres.2011.10.030. PMID 22113148.CS1 maint: Multiple names: authors list (link)
  43. 1 2 "Cardiovascular Effects of Ambient Particulate Air Pollution Exposure". Circulation. 121 (25): 2755–65. 2010. doi:10.1161/CIRCULATIONAHA.109.893461. PMC 2924678. PMID 20585020.
  44. 1 2 Tunstall-Pedoe, H. (2011). "Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose". Heart. 97 (6): 442–444. doi:10.1136/hrt.2010.214858. ISSN 1355-6037.
  45. ↑ World Health Organization (2007). Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Cardiovascular Risk. World Health Organization. ISBN 978-92-4-154717-8.
  46. ↑ Hernandez, Adrian V.; van Staa, Tjeerd-Pieter; Gulliford, Martin; Ng, Edmond S.-W.; Goldacre, Ben; Smeeth, Liam (2014). "Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather than Population Risk?". PLoS ONE. 9 (10): e106455. doi:10.1371/journal.pone.0106455. ISSN 1932-6203.
  47. ↑ Hlatky, M. A.; Greenland, P.; Arnett, D. K.; Ballantyne, C. M.; Criqui, M. H.; Elkind, M. S.V.; Go, A. S.; Harrell, F. E.; Hong, Y.; Howard, B. V.; Howard, V. J.; Hsue, P. Y.; Kramer, C. M.; McConnell, J. P.; Normand, S.-L. T.; O'Donnell, C. J.; Smith, S. C.; Wilson, P. W.F. (2009). "Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association". Circulation. 119 (17): 2408–2416. doi:10.1161/CIRCULATIONAHA.109.192278. ISSN 0009-7322.
  48. ↑ Eckel, Robert H; Cornier, Marc-Andre (2014). "Update on the NCEP ATP-III emerging cardiometabolic risk factors". BMC Medicine. 12 (1): 115. doi:10.1186/1741-7015-12-115. ISSN 1741-7015.
  49. ↑ Inaba, Y; Chen, JA; Bergmann, SR (January 2012). "Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis". Atherosclerosis. 220 (1): 128–33. doi:10.1016/j.atherosclerosis.2011.06.044. PMID 21764060.
  50. ↑ Bertazzo, S และคณะ (2013). "Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification". Nature Materials. 12: 576–583.CS1 maint: Uses authors parameter (link) CS1 maint: Explicit use of et al. (link)
  51. ↑ Vanhecke, TE; Miller, WM; Franklin, BA; Weber, JE; McCullough, PA (October 2006). "Awareness, knowledge, and perception of heart disease among adolescents". Eur J Cardiovasc Prev Rehabil. 13 (5): 718–23. doi:10.1097/01.hjr.0000214611.91490.5e. PMID 17001210.CS1 maint: Multiple names: authors list (link)
  52. ↑ Highlander, P; Shaw, GP (2010). "Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics". Ther Adv Cardiovasc Dis. 4 (1): 43–54. doi:10.1177/1753944709354305.CS1 maint: Multiple names: authors list (link)
  53. ↑ NPS Medicinewise (2011-03-01). "NPS Prescribing Practice Review 53: Managing lipids". สืบค้นเมื่อ 2011-08-01.
  54. ↑ Kvan, E; Pettersen, KI; Sandvik, L; Reikvam, A (2007). "High mortality in diabetic patient with acute myocardial infarction: cardiovascular co-morbidities contribute most to the high risk". Int J Cardiol. 121 (2): 184–188. doi:10.1016/j.ijcard.2006.11.003.CS1 maint: Multiple names: authors list (link)
  55. ↑ Norhammar A., Malmberg K., Diderhol E., Lagerqvist B., Lindahl B., Ryde; และคณะ (2004). "Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J". Am Coll Cardiol. 43 (4): 585–591. doi:10.1016/j.jacc.2003.08.050.CS1 maint: Multiple names: authors list (link)
  56. ↑ DECODE , European Diabetes Epidemiology Group (1999). "Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria". Lancet. 354 (9179): 617–621. doi:10.1016/S0140-6736(98)12131-1. PMID 10466661.
  57. 1 2 Moyer, VA; U.S. Preventive Services Task Force (2012-10-02). "Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 157 (7): 512–8. doi:10.7326/0003-4819-157-7-201210020-00514. PMID 22847227.
  58. ↑ Maron, B. J.; Friedman, R. A.; Kligfield, P.; Levine, B. D.; Viskin, S.; Chaitman, B. R.; Okin, P. M.; Saul, J. P.; Salberg, L.; Van Hare, G. F.; Soliman, E. Z.; Chen, J.; Matherne, G. P.; Bolling, S. F.; Mitten, M. J.; Caplan, A.; Balady, G. J.; Thompson, P. D. (2014-09-15). "Assessment of the 12-Lead ECG as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12-25 Years of Age) : A Scientific Statement From the American Heart Association and the American College of Cardiology". Circulation. 130 (15): 1303–1334. doi:10.1161/CIR.0000000000000025.
  59. ↑ Chou, Roger (2015-03-17). "Cardiac Screening With Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging: Advice for High-Value Care From the American College of Physicians". Annals of Internal Medicine. 162 (6): 438. doi:10.7326/M14-1225.
  60. ↑ Wang, TJ; Gona, P; Larson, MG; Tofler, GH; Levy, D; Newton-Cheh, C; Jacques, PF; Rifai, N; Selhub, J; Robins, SJ; Benjamin, EJ; D'Agostino, RB; Vasan, RS (2006). "Multiple biomarkers for the prediction of first major cardiovascular events and death". N. Engl. J. Med. 355 (25): 2631-billy bob joe9. doi:10.1056/NEJMoa055373. PMID 17182988.CS1 maint: Multiple names: authors list (link)
  61. ↑ Spence, JD (2006). "Technology Insight: ultrasound measurement of carotid plaque—patient management, genetic research, and therapy evaluation". Nat Clin Pract Neurol. 2 (11): 611–9. doi:10.1038/ncpneuro0324. PMID 17057748.
  62. 1 2 3 4 "Prevention: Heart Attack". NHS Direct. 2016-10-11. Archived from the original on 2018-09-26. สืบค้นเมื่อ 2018-09-26.
  63. ↑ Ignarro, LJ; Balestrieri, ML; Napoli, C (2007-01-15). "Nutrition, physical activity, and cardiovascular disease: an update". Cardiovascular research. 73 (2): 326–40. doi:10.1016/j.cardiores.2006.06.030. PMID 16945357.
  64. 1 2 Wang, X; Ouyang, Y; Liu, J; Zhu, M; Zhao, G; Bao, W; Hu, FB (2014-07-29). "Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies". BMJ (Clinical research ed.). 349: g4490. doi:10.1136/bmj.g4490. PMC 4115152. PMID 25073782.
  65. ↑ The National Heart, Lung, and Blood Institute (NHLBI) (2011-10-05). "How To Prevent and Control Coronary Heart Disease Risk Factors - NHLBI, NIH". Archived from the original on 2014-10-04. สืบค้นเมื่อ 2011-10-05.CS1 maint: Multiple names: authors list (link)
  66. ↑ "Alcohol and recreational drug use". Heart and Stroke Foundation of Canada. Archived from the original on 2018-07-10. สืบค้นเมื่อ 2018-09-27.
  67. ↑ Klatsky, AL (May 2009). "Alcohol and cardiovascular diseases". Expert Rev Cardiovasc Ther. 7 (5): 499–506. doi:10.1586/erc.09.22. PMID 19419257.
  68. ↑ Udell, Jay (MD). "Ask a cardiologist: Alcohol and heart health". Heart & Stroke Foundation, Canda. Archived from the original on 2018-09-26. สืบค้นเมื่อ 2018-09-27.CS1 maint: Uses authors parameter (link)
  69. ↑ McMahan, C. Alex; Gidding, Samuel S.; Malcom, Gray T.; Tracy, Richard E.; Strong, Jack P.; McGill, Henry C. (2006-10-01). "Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis". Pediatrics. 118 (4): 1447–1455. doi:10.1542/peds.2006-0970. ISSN 1098-4275. PMID 17015535.
  70. ↑ Raitakari, Olli T.; R?nnemaa, Tapani; J?rvisalo, Mikko J.; Kaitosaari, Tuuli; Volanen, Iina; Kallio, Katariina; Lagstr?m, Hanna; Jokinen, Eero; Niinikoski, Harri (2005-12-13). "Endothelial function in healthy 11-year-old children after dietary intervention with onset in infancy: the Special Turku Coronary Risk Factor Intervention Project for children (STRIP)". Circulation. 112 (24): 3786–3794. doi:10.1161/CIRCULATIONAHA.105.583195. ISSN 1524-4539. PMID 16330680.
  71. ↑ McTigue, KM; Hess, R; Ziouras, J (September 2006). "Obesity in older adults: a systematic review of the evidence for diagnosis and treatment". Obesity (Silver Spring). 14 (9): 1485–97. doi:10.1038/oby.2006.171. PMID 17030958.CS1 maint: Multiple names: authors list (link)
  72. ↑ Linden, W; Stossel, C; Maurice, J (April 1996). "Psychosocial interventions for patients with coronary artery disease: a meta-analysis". Arch. Intern. Med. 156 (7): 745–52. doi:10.1001/archinte.1996.00440070065008. PMID 8615707.CS1 maint: Multiple names: authors list (link)
  73. ↑ Thompson, D. R.; Ski, C. F. (2013). "Psychosocial interventions in cardiovascular disease - what are they?". European Journal of Preventive Cardiology. 20 (6): 916–917. doi:10.1177/2047487313494031. ISSN 2047-4873.
  74. ↑ Wei, J; Rooks, C; Ramadan, R; Shah, AJ; Bremner, JD; Quyyumi, AA; Kutner, M; Vaccarino, V (2014-07-15). "Meta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary artery disease". The American journal of cardiology. 114 (2): 187–92. doi:10.1016/j.amjcard.2014.04.022. PMID 24856319.
  75. ↑ Zamir, M (2005). The Physics of Coronary Blood Flow. Springer Science and Business Media. p. 387. ISBN 978-0387-25297-1.CS1 maint: Uses authors parameter (link)
  76. ↑ Akashi, YJ; Nef, HM; M?llmann, H; Ueyama, T (2010). "Stress cardiomyopathy". Annu. Rev. Med. 61: 271–86. doi:10.1146/annurev.med.041908.191750. PMID 19686084.CS1 maint: Uses authors parameter (link)
  77. ↑ Pelliccia, F; Greco, C; Vitale, C; Rosano, G; Gaudio, C; Kaski, JC (August 2014). "Takotsubo syndrome (stress cardiomyopathy) : an intriguing clinical condition in search of its identity". The American Journal of Medicine. 127 (8): 699–704. doi:10.1016/j.amjmed.2014.04.004. PMID 24754972.
  78. ↑ Marshall, IJ; Wolfe, CD; McKevitt, C (2012-07-09). "Lay perspectives on hypertension and drug adherence: systematic review of qualitative research". BMJ (Clinical research ed.). 345: e3953. doi:10.1136/bmj.e3953. PMC 3392078. PMID 22777025.
  79. ↑ Dickinson, HO; Mason, JM; Nicolson, DJ; Campbell, F; Beyer, FR; Cook, JV; Williams, B; Ford, GA (February 2006). "Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials". Journal of Hypertension. 24 (2): 215–33. doi:10.1097/01.hjh.0000199800.72563.26. PMID 16508562.
  80. ↑ Abbott, RA; Whear, R; Rodgers, LR; Bethel, A; Thompson Coon, J; Kuyken, W; Stein, K; Dickens, C (May 2014). "Effectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular disease: A systematic review and meta-analysis of randomised controlled trials". Journal of psychosomatic research. 76 (5): 341–51. doi:10.1016/j.jpsychores.2014.02.012. PMID 24745774.
  81. ↑ Moyer, VA; U.S. Preventive Services Task Force (2012-09-04). "Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 157 (5): 367–71. doi:10.7326/0003-4819-157-5-201209040-00486. PMID 22733153.
  82. ↑ Li, C; Lv, Z; Shi, Z; Zhu, Y; Wu, Y; Li, L; Iheozor-Ejiofor, Z (2014-08-15). "Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis". The Cochrane database of systematic reviews. 8: CD009197. doi:10.1002/14651858.CD009197.pub2. PMID 25123257.
  83. ↑ Seron, P; Lanas, F; Pardo Hernandez, H; Bonfill Cosp, X (2014-08-13). "Exercise for people with high cardiovascular risk". The Cochrane database of systematic reviews. 8: CD009387. doi:10.1002/14651858.CD009387.pub2. PMID 25120097.
  84. ↑ Walker, C; Reamy, BV (April 2009). "Diets for cardiovascular disease prevention: what is the evidence?". Am Fam Physician. 79 (7): 571–8. PMID 19378874.CS1 maint: Multiple names: authors list (link)
  85. ↑ Nordmann, AJ; Suter-Zimmermann, K; Bucher, HC; Shai, I; Tuttle, KR; Estruch, R; Briel, M (September 2011). "Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors". The American Journal of Medicine. 124 (9): 841–51.e2. doi:10.1016/j.amjmed.2011.04.024. PMID 21854893.
  86. ↑ Sacks, FM; Svetkey, LP; Vollmer, WM; และคณะ (January 2001). "Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group". N. Engl. J. Med. 344 (1): 3–10. doi:10.1056/NEJM200101043440101. PMID 11136953.CS1 maint: Multiple names: authors list (link)
  87. ↑ Obarzanek, E; Sacks, FM; Vollmer, WM; และคณะ (July 2001). "Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial". Am. J. Clin. Nutr. 74 (1): 80–9. PMID 11451721.CS1 maint: Multiple names: authors list (link)
  88. ↑ Azadbakht, L; Mirmiran, P; Esmaillzadeh, A; Azizi, T; Azizi, F (December 2005). "Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome". Diabetes Care. 28 (12): 2823–31. doi:10.2337/diacare.28.12.2823. PMID 16306540.CS1 maint: Multiple names: authors list (link)
  89. ↑ Logan, AG (March 2007). "DASH Diet: time for a critical appraisal?". Am. J. Hypertens. 20 (3): 223–4. doi:10.1016/j.amjhyper.2006.10.006. PMID 17324730.
  90. ↑ Threapleton, D. E.; Greenwood, D. C.; Evans, C. E. L.; Cleghorn, C. L.; Nykjaer, C.; Woodhead, C.; Cade, J. E.; Gale, C. P.; Burley, V. J. (2013-12-19). "Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis". BMJ. 347 (dec19 2): f6879–f6879. doi:10.1136/bmj.f6879. PMC 3898422. PMID 24355537.
  91. ↑ "Fats and fatty acids in human nutrition Report of an expert consultation". World Health Organization. WHO/FAO. สืบค้นเมื่อ 2014-12-20.
  92. 1 2 3 Willett, WC (July 2012). "Dietary fats and coronary heart disease". Journal of internal medicine. 272 (1): 13–24. doi:10.1111/j.1365-2796.2012.02553.x. PMID 22583051.
  93. 1 2 3 Chowdhury, Rajiv; Warnakula, Samantha; Kunutsor, Setor; Crowe, Francesca; Ward, Heather A.; Johnson, Laura; Franco, Oscar H.; Butterworth, Adam S.; Forouhi, Nita G.; Thompson, Simon G.; Khaw, Kay-Tee; Mozaffarian, Dariush; Danesh, John; Di Angelantonio, Emanuele (2014-03-18). "Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk". Annals of Internal Medicine. 160 (6): 398–406. doi:10.7326/M13-1788. PMID 24723079.
  94. 1 2 Ramsden, CE; Zamora, D; Leelarthaepin, B; Majchrzak-Hong, SF; Faurot, KR; Suchindran, CM; Ringel, A; Davis, JM; Hibbeln, JR (2013-02-04). "Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis". BMJ (Clinical research ed.). 346: e8707. doi:10.1136/bmj.e8707. PMID 23386268.
  95. 1 2 "Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies". BMJ. 351 (h3978). 2015-08-12. doi:10.1136/bmj.h3978. PMC 4532752. PMID 26268692.
  96. ↑ Hooper, L; Summerbell, CD; Thompson, R; Sills, D; Roberts, FG; Moore, HJ; Davey Smith, G (2012-05-16). "Reduced or modified dietary fat for preventing cardiovascular disease". Cochrane database of systematic reviews (Online). 5: CD002137. doi:10.1002/14651858.CD002137.pub3. PMID 22592684.
  97. ↑ Siri-Tarino, Patty W; Sun, Qi; Hu, Frank B; Krauss, Ronald M (2010). "Saturated fat, carbohydrate, and cardiovascular disease". American Journal of Clinical Nutrition. 91 (3): 502–509. doi:10.3945/ajcn.2008.26285. PMC 2824150. PMID 20089734.CS1 maint: Multiple names: authors list (link)
  98. ↑ Micha, R; Mozaffarian, D (October 2010). "Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence". Lipids. 45 (10): 893–905. doi:10.1007/s11745-010-3393-4. PMC 2950931. PMID 20354806.
  99. ↑ Astrup, A; Dyerberg, J; Elwood, P; Hermansen, K; Hu, FB; Jakobsen, MU; Kok, FJ; Krauss, RM; Lecerf, JM; LeGrand, P; Nestel, P; Ris?rus, U; Sanders, T; Sinclair, A; Stender, S; Tholstrup, T; Willett, WC (April 2011). "The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?". The American Journal of Clinical Nutrition. 93 (4): 684–8. doi:10.3945/ajcn.110.004622. PMC 3138219. PMID 21270379.
  100. ↑ Rizos, EC; Ntzani, EE; Bika, E; Kostapanos, MS; Elisaf, MS (2012-09-12). "Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis". JAMA: the Journal of the American Medical Association. 308 (10): 1024–33. doi:10.1001/2012.jama.11374. PMID 22968891.
  101. 1 2 Taylor, RS; Ashton, KE; Moxham, T; Hooper, L; Ebrahim, S (2011-07-06). "Reduced dietary salt for the prevention of cardiovascular disease". Cochrane database of systematic reviews (Online) (7): CD009217. doi:10.1002/14651858.CD009217. PMID 21735439.
  102. 1 2 He, F J; MacGregor, GA (2011). "Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials" (PDF). The Lancet. 378 (9789): 380–382. doi:10.1016/S0140-6736(11)61174-4. PMID 21803192.
  103. ↑ Paterna, S; Gaspare, P; Fasullo, S; Sarullo, FM; Di Pasquale, P (2008). "Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?". Clin Sci (Lond). 114 (3): 221–230. doi:10.1042/CS20070193. PMID 17688420.
  104. 1 2 Bochud, M; Marques-Vidal, P; Burnier, M; Paccaud, F (2012). "Dietary Salt Intake and Cardiovascular Disease: Summarizing the Evidence". Public Health Reviews. 33: 530–552.
  105. ↑ Cook, N R; และคณะ (2007). "Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)". BMJ. 334 (7599): 334. doi:10.1136/bmj.39147.604896.55. PMC 1857760. PMID 17449506.
  106. ↑ Berger, JS; Lala, A; Krantz, MJ; Baker, GS; Hiatt, WR (July 2011). "Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials". American Heart Journal. 162 (1): 115–24.e2. doi:10.1016/j.ahj.2011.04.006. PMID 21742097.
  107. ↑ "Final Recommendation Statement Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication". us preventive services task force. March 2009. สืบค้นเมื่อ 2015-01-15.
  108. 1 2 Gutierrez, J; Ramirez, G; Rundek, T; Sacco, RL (2012-06-25). "Statin Therapy in the Prevention of Recurrent Cardiovascular Events: A Sex-Based Meta-analysisStatin Therapy to Prevent Recurrent CV Events". Archives of Internal Medicine. 172 (12): 909–19. doi:10.1001/archinternmed.2012.2145. PMID 22732744.
  109. ↑ Taylor, F; Huffman, MD; Macedo, AF; Moore, TH; Burke, M; Davey Smith, G; Ward, K; Ebrahim, S (2013-01-31). "Statins for the primary prevention of cardiovascular disease". Cochrane database of systematic reviews (Online). 1: CD004816. doi:10.1002/14651858.CD004816.pub5. PMID 23440795.
  110. ↑ Downs, JR; O'Malley, PG (2015-08-18). "Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline". Annals of Internal Medicine. 163 (4): 291–7. doi:10.7326/m15-0840. PMID 26099117.
  111. ↑ Francis, DP (2011-05-19). "Duration and magnitude of the effect of a single statin tablet in primary prevention of cardiovascular events". International journal of cardiology. 149 (1): 102–7. doi:10.1016/j.ijcard.2010.11.013. PMID 21183232.
  112. ↑ Keene, D; Price, C; Shun-Shin, MJ; Francis, DP (2014-07-18). "Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients". BMJ (Clinical research ed.). 349: g4379. doi:10.1136/bmj.g4379. PMC 4103514. PMID 25038074.
  113. ↑ American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Chest Physicians and American Thoracic Society, สืบค้นเมื่อ 2013-01-06
  114. ↑ Bhupathiraju, SN; Tucker, KL (2011-08-17). "Coronary heart disease prevention: nutrients, foods, and dietary patterns". Clinica chimica acta; international journal of clinical chemistry. 412 (17–18): 1493–514. doi:10.1016/j.cca.2011.04.038. PMID 21575619.
  115. ↑ Myung, SK; Ju, W; Cho, B; Oh, SW; Park, SM; Koo, BK; Park, BJ; for the Korean Meta-Analysis (KORMA) Study, Group (2013-01-18). "Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials". BMJ (Clinical research ed.). 346: f10. doi:10.1136/bmj.f10. PMC 3548618. PMID 23335472.
  116. ↑ Fortmann, SP; Burda, BU; Senger, CA; Lin, JS; Whitlock, EP (2013-11-12). "Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force". Annals of Internal Medicine. 159 (12): 824–34. doi:10.7326/0003-4819-159-12-201312170-00729. PMID 24217421.
  117. ↑ Bruckert, E; Labreuche, J; Amarenco, P (June 2010). "Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis". Atherosclerosis. 210 (2): 353–61. doi:10.1016/j.atherosclerosis.2009.12.023. PMID 20079494.
  118. ↑ Lavigne, PM; Karas, RH (2013-01-29). "The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression". Journal of the American College of Cardiology. 61 (4): 440–6. doi:10.1016/j.jacc.2012.10.030. PMID 23265337.
  119. ↑ Jee, SH; Miller, ERIII; Guallar, E; และคณะ (2002). "The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials". Am J Hypertens. 15 (8): 691–696. doi:10.1016/S0895-7061(02)02964-3. PMID 12160191.CS1 maint: Multiple names: authors list (link)
  120. ↑ Zipes, DP; Camm, AJ; Borggrefe, M; และคณะ (2012). "ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (10): e385–e484. doi:10.1161/CIRCULATIONAHA.106.178233. PMID 16935995.CS1 maint: Multiple names: authors list (link)
  121. ↑ Kwak, SM; Myung, SK; Lee, YJ; Seo, HG; for the Korean Meta-analysis Study, Group (2012-04-09). "Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized, Double-blind, Placebo-Controlled Trials". Archives of Internal Medicine. 172 (9): 686. doi:10.1001/archinternmed.2012.262. PMID 22493407.
  122. ↑ "WHO Disease and injury country estimates". World Health Organization. 2009. สืบค้นเมื่อ 2009-11-11.
  123. ↑ "Why South Asians Facts". Indian Heart Association. 2015-04-29. Archived from the original on 2018-09-01.
  124. ↑ "ภัยเงียบ!!"โรคหัวใจ"ดับชีวิตคนไทยเฉลี่ย 6 คนทุกชั่วโมง". Manager. 2014-09-30. Archived from the original on 2018-12-03.
  125. ↑ Morris, J. N.; Crawford, Margaret D. (1958). "Coronary Heart Disease and Physical Activity of Work". British Medical Journal. 2 (5111): 1485–1496. doi:10.1136/bmj.2.5111.1485. PMC 2027542. PMID 13608027.CS1 maint: Multiple names: authors list (link)
  126. ↑ Karakas, M; Koenig, W (December 2009). "CRP in cardiovascular disease". Herz. 34 (8): 607–13. doi:10.1007/s00059-009-3305-7. PMID 20024640.CS1 maint: Multiple names: authors list (link)
  127. ↑ "Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality". 2010. PMID 20448212.
  128. ↑ Venuraju, SM; Yerramasu, A; Corder, R; Lahiri, A (May 2010). "Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity". J. Am. Coll. Cardiol. 55 (19): 2049–61. doi:10.1016/j.jacc.2010.03.013. PMID 20447527.CS1 maint: Multiple names: authors list (link)
  129. ↑ Andraws, R; Berger, JS; Brown, DL (June 2005). "Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials". JAMA. 293 (21): 2641–7. doi:10.1001/jama.293.21.2641. PMID 15928286.CS1 maint: Multiple names: authors list (link)
  130. ↑ Dominguez-Rodriguez, Alberto (January 2012). "Melatonin and Cardiovascular Disease: Myth or Reality?". Rev Esp Cardiol. 65: 215–218.

ใกล้เคียง

โรคระบบหัวใจหลอดเลือด โรคระบาดทั่ว โรคระบาดยุสตินิอานุส โรคระบบหายใจ โรคระบาด โรคระบาดแอนโทนิน โรคระบาดครั้งใหญ่ในลอนดอน โรคระบาดทางการเงิน โรคระบบประสาทเสื่อม โรคของระบบประสาท

แหล่งที่มา

WikiPedia: โรคระบบหัวใจหลอดเลือด http://www.nps.org.au/health_professionals/publica... http://www.heartandstroke.ca/articles/ask-a-cardio... http://www.heartandstroke.ca/heart/risk-and-preven... http://www.bmj.com/content/334/7599/885 http://www.diseasesdatabase.com/ddb28808.htm http://www.icd9data.com/getICD9Code.ashx?icd9=429.... http://www.medicinenet.com/heart_disease_coronary_... http://www.thaiglossary.com/search/cardiovascular%... http://www.publichealthreviews.eu/show/f/85 http://www.nhlbi.nih.gov/health/health-topics/topi...